Accordingly, we assumed that LINC00663 may facilitate the inflammation and angiogenesis of BC by regulating NR2F1 via EBF1, hoping to provide valuable references for developing new molecular targets for the treatment of BC. The gene discussed is EBF1; the disease is breast cancer.